-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Summit Healthcare Acquisition (SMIH) and The Competition Critical Analysis
Summit Healthcare Acquisition (SMIH) and The Competition Critical Analysis
Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 publicly-traded companies in the "Holding & other investment offices" industry, but how does it contrast to its competitors? We will compare Summit Healthcare Acquisition to similar businesses based on the strength of its valuation, profitability, institutional ownership, earnings, risk, analyst recommendations and dividends.
Earnings and Valuation
This table compares Summit Healthcare Acquisition and its competitors gross revenue, earnings per share and valuation.
Get Summit Healthcare Acquisition alerts:Gross Revenue | Net Income | Price/Earnings Ratio | |
Summit Healthcare Acquisition | N/A | -$550,000.00 | 12.59 |
Summit Healthcare Acquisition Competitors | $1.72 billion | $88.36 million | 23.10 |
Summit Healthcare Acquisition's competitors have higher revenue and earnings than Summit Healthcare Acquisition. Summit Healthcare Acquisition is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Volatility and Risk
Summit Healthcare Acquisition has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's competitors have a beta of 0.05, meaning that their average share price is 95% less volatile than the S&P 500.Profitability
This table compares Summit Healthcare Acquisition and its competitors' net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Summit Healthcare Acquisition | N/A | 46.53% | 8.78% |
Summit Healthcare Acquisition Competitors | 11.67% | -68.35% | 2.51% |
Analyst Recommendations
This is a summary of recent ratings and target prices for Summit Healthcare Acquisition and its competitors, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Summit Healthcare Acquisition | 0 | 0 | 0 | 0 | N/A |
Summit Healthcare Acquisition Competitors | 113 | 593 | 889 | 18 | 2.50 |
As a group, "Holding & other investment offices" companies have a potential upside of 69.95%. Given Summit Healthcare Acquisition's competitors higher possible upside, analysts plainly believe Summit Healthcare Acquisition has less favorable growth aspects than its competitors.
Institutional and Insider Ownership
64.3% of shares of all "Holding & other investment offices" companies are held by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Summit Healthcare Acquisition competitors beat Summit Healthcare Acquisition on 8 of the 10 factors compared.
Summit Healthcare Acquisition Company Profile
(Get Rating)
Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.
Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 publicly-traded companies in the "Holding & other investment offices" industry, but how does it contrast to its competitors? We will compare Summit Healthcare Acquisition to similar businesses based on the strength of its valuation, profitability, institutional ownership, earnings, risk, analyst recommendations and dividends.
峰會醫療收購(NASDAQ:SMIH — 獲得評級)是「控股及其他投資辦公室」行業中 710 家上市公司之一,但它與競爭對手的對比如何?我們將根據其估值、盈利能力、機構所有權、收益、風險、分析師建議和股息的實力,將 Summit Healthcare 收購與同類企業進行比較。
Earnings and Valuation
收益及估值
This table compares Summit Healthcare Acquisition and its competitors gross revenue, earnings per share and valuation.
此表格比較峰會醫療收購及其競爭對手的總收入、每股盈利和估值。
Gross Revenue | Net Income | Price/Earnings Ratio | |
Summit Healthcare Acquisition | N/A | -$550,000.00 | 12.59 |
Summit Healthcare Acquisition Competitors | $1.72 billion | $88.36 million | 23.10 |
總收入 | 淨收入 | 市盈比率 | |
峰會醫療收購 | N/A | -$550,000.00 | 12.59 |
峰會醫療收購競爭者 | 十二億七千萬元 | 八千八百三十六萬元 | 23.10 |
Summit Healthcare Acquisition's competitors have higher revenue and earnings than Summit Healthcare Acquisition. Summit Healthcare Acquisition is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
峰會醫療收購的競爭對手擁有更高的收入和收益比峰會醫療收購。Summit Healthcare 收購以低於競爭對手的價格與收益比率進行交易,這表明它目前比其他行業中的公司更經濟實惠。
Volatility and Risk
波動性和風險
Profitability
盈利
This table compares Summit Healthcare Acquisition and its competitors' net margins, return on equity and return on assets.
本表比較峰峰醫療收購及其競爭對手的淨利潤率、權益回報率及資產回報率。
Net Margins | Return on Equity | Return on Assets | |
Summit Healthcare Acquisition | N/A | 46.53% | 8.78% |
Summit Healthcare Acquisition Competitors | 11.67% | -68.35% | 2.51% |
淨利潤 | 權益回報率 | 資產回報率 | |
峰會醫療收購 | N/A | 46.53% | 8.78% |
峰會醫療收購競爭者 | 11.67% | -68.35% | 2.51% |
Analyst Recommendations
分析師推薦
This is a summary of recent ratings and target prices for Summit Healthcare Acquisition and its competitors, as provided by MarketBeat.com.
這是由 MarketBeat.com 提供的峰頂醫療收購及其競爭對手的最新評分和目標價格的摘要。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Summit Healthcare Acquisition | 0 | 0 | 0 | 0 | N/A |
Summit Healthcare Acquisition Competitors | 113 | 593 | 889 | 18 | 2.50 |
銷售評級 | 保留評分 | 購買評級 | 強大的買入評級 | 評級分數 | |
峰會醫療收購 | 0 | 0 | 0 | 0 | N/A |
峰會醫療收購競爭者 | 113 | 593 | 889 | 18 | 2.50 |
As a group, "Holding & other investment offices" companies have a potential upside of 69.95%. Given Summit Healthcare Acquisition's competitors higher possible upside, analysts plainly believe Summit Healthcare Acquisition has less favorable growth aspects than its competitors.
作為一個集團,「控股及其他投資辦事處」公司的潛在上升空間為 69.95%。鑑於 Summit Healthcare 收購的競爭對手可能具有較高的上行空間,分析師清楚地認為峰會醫療收購比競爭對手具有較不利的增長
Institutional and Insider Ownership
機構和內幕所有權
64.3% of shares of all "Holding & other investment offices" companies are held by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
所有「控股及其他投資辦事處」公司的 64.3% 股份均由機構投資者持有。所有「控股及其他投資辦事處」公司的 17.6% 股份均由內幕人士持有。強大的機構所有權表明,捐贈基金,大型資金經理和對沖基金認為公司長期的表現將優於市場。
Summary
摘要
Summit Healthcare Acquisition competitors beat Summit Healthcare Acquisition on 8 of the 10 factors compared.
峰會醫療收購競爭對手在 10 個因素中的 8 個因素中擊敗了 Summit 醫療收購。
Summit Healthcare Acquisition Company Profile
峰頂醫療收購公司簡介
(Get Rating)
(取得評分)
Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.
峰頂醫療收購公司沒有重大業務。它打算與一個或多個企業或實體實施合併,股票交換,資產收購,股票購買,重組或類似的業務組合。該公司於 2020 年註冊成立,總部位於香港中環。
Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收峰會醫療收購的最新消息和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Summit 醫療保健收購和相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧